Skip to main content
MedPathMedPath Home
Clinical Trials/RPCEC00000323
RPCEC00000323
Recruiting
未知

TRANSFUSION WITH CONVALING PLASMA IMMUNIZES THE ASYMPTOMATIC PATIENT WITH COVID INFECTION 19 THAT FOR MORE THAN 30 DAYS IS POSITIVE SARS CoV-2 PCR (COVID-19)

Institute of Hematology and Immunology Dr. Jose Manuel Ballester Santovenia”0 sitesJuly 3, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBetacoronavirusCOVID-19 infectionCOVID-19Coronavirus InfectionsSARS VirusCoronaviridae InfectionsSevere Acute Respiratory Syndrome

Overview

Phase
未知
Intervention
Not specified
Conditions
Betacoronavirus
Sponsor
Institute of Hematology and Immunology Dr. Jose Manuel Ballester Santovenia”
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 3, 2020
End Date
December 12, 2020
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Institute of Hematology and Immunology Dr. Jose Manuel Ballester Santovenia”

Eligibility Criteria

Inclusion Criteria

  • •1\. Adult with SARS\-CoV2 infection diagnosed by RT\-PCR.
  • •2\. Remain asymptomatic with SARS\-CoV2 positive PCR for more than 30 days.
  • •3\. That the antibody kit tests do not detect antibodies.
  • •4\. That there is no history of anaphylaxis reactions with blood products.
  • •5\. That at the clinical evaluation by the attending physician there are no contraindications for plasma transfusion.
  • •6\. That the patient or their relatives give their informed consent to receive this donation.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Effect of convalescent plasma in patients with severe COVI-19Coronavirus infectionSepsisC01.925.782.600.550.200C01.757
RBR-4vm3yyInstituto Estadual de Hematologia Arthur Siqueira Cavalcanti
Completed
Not Applicable
Transfusion of fresh frozen plasma in non bleeding ICU patientscoagulopathyimpaired clotting100644771002496710043413
NL-OMON38043Academisch Medisch Centrum400
Completed
Phase 1
The prevention of transfusion reactions by washed platelet concentrates in pediatric patientsAcute leukemia
JPRN-UMIN000002610Shinshu University Hospital30
Not yet recruiting
Not Applicable
A trial to compare two treatment options for Landry Guillain Barre Syndrome (A form of paralysis) in childreHealth Condition 1: G610- Guillain-Barre syndrome
CTRI/2020/12/029502Manjinder Singh Randhawa
Completed
Not Applicable
Hemadsorption through supportive establishment of an Oxiris® filter in septic shock with suspected cytokine release syndrome - a randomized controlled intervention studyR57.2Septic shock
DRKS00027287Klinik für Anästhesiologie Universitätsklinikum Heidelberg19